Santen Pharmaceutical Co., Ltd. (SNPHF)
OTCMKTS
· Delayed Price · Currency is USD
10.53
-0.62 (-5.53%)
At close: Dec 9, 2024
Santen Pharmaceutical Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 6, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,198 | 3,697 | 3,192 | 4,043 | 5,505 | 6,896 | Upgrade
|
| Market Cap Growth | -3.17% | 15.82% | -21.04% | -26.56% | -20.18% | 16.13% | Upgrade
|
| Enterprise Value | 2,667 | 3,150 | 2,727 | 3,479 | 5,022 | 6,143 | Upgrade
|
| Last Close Price | 10.53 | 9.35 | 8.58 | 11.37 | 13.86 | 16.83 | Upgrade
|
| PE Ratio | 18.29 | 21.00 | - | 18.04 | 89.19 | 31.42 | Upgrade
|
| PS Ratio | 1.83 | 1.85 | 1.52 | 1.84 | 2.44 | 3.07 | Upgrade
|
| PB Ratio | 1.95 | 1.83 | 1.45 | 1.46 | 1.98 | 2.45 | Upgrade
|
| P/TBV Ratio | 2.70 | 2.52 | 2.15 | 2.37 | 3.13 | 4.05 | Upgrade
|
| P/FCF Ratio | 11.96 | 8.83 | 21.36 | 17.11 | 17.56 | 21.75 | Upgrade
|
| P/OCF Ratio | 10.00 | 7.70 | 11.42 | 10.66 | 15.69 | 18.58 | Upgrade
|
| EV/Sales Ratio | 1.31 | 1.58 | 1.30 | 1.59 | 2.23 | 2.74 | Upgrade
|
| EV/EBITDA Ratio | 6.12 | 6.77 | 6.90 | 7.98 | 7.90 | 11.71 | Upgrade
|
| EV/EBIT Ratio | 8.50 | 9.13 | 10.27 | 11.78 | 10.38 | 16.58 | Upgrade
|
| EV/FCF Ratio | 9.08 | 7.52 | 18.24 | 14.72 | 16.02 | 19.37 | Upgrade
|
| Debt / Equity Ratio | - | 0.11 | 0.12 | 0.10 | 0.03 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.49 | 0.69 | 0.62 | 0.14 | 0.22 | Upgrade
|
| Debt / FCF Ratio | - | 0.55 | 1.82 | 1.15 | 0.29 | 0.36 | Upgrade
|
| Asset Turnover | 0.73 | 0.70 | 0.63 | 0.62 | 0.62 | 0.60 | Upgrade
|
| Inventory Turnover | 2.67 | 2.99 | 2.95 | 2.79 | 2.56 | 2.69 | Upgrade
|
| Quick Ratio | 1.87 | 1.99 | 1.84 | 1.91 | 2.02 | 2.64 | Upgrade
|
| Current Ratio | 2.61 | 2.54 | 2.38 | 2.39 | 2.63 | 3.23 | Upgrade
|
| Return on Equity (ROE) | 9.45% | 8.92% | -4.76% | 8.45% | 2.18% | 7.30% | Upgrade
|
| Return on Assets (ROA) | 7.75% | 7.61% | 5.01% | 5.20% | 8.25% | 6.23% | Upgrade
|
| Return on Capital (ROIC) | 11.02% | 9.74% | 6.31% | 6.53% | 10.58% | 8.15% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.02% | 15.22% | 10.64% | 9.85% | 16.52% | 11.68% | Upgrade
|
| Earnings Yield | 5.47% | 4.76% | -3.52% | 5.54% | 1.12% | 3.18% | Upgrade
|
| FCF Yield | 9.19% | 11.33% | 4.68% | 5.85% | 5.69% | 4.60% | Upgrade
|
| Dividend Yield | 1.11% | 2.33% | 2.80% | 2.32% | 1.83% | 1.49% | Upgrade
|
| Payout Ratio | 44.13% | 44.59% | - | 44.07% | 163.81% | 43.95% | Upgrade
|
| Buyback Yield / Dilution | 4.34% | 4.98% | 3.26% | -0.02% | -0.03% | 1.75% | Upgrade
|
| Total Shareholder Return | 5.45% | 7.31% | 6.06% | 2.30% | 1.79% | 3.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.